Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Julphar
QuintilesIMS
Argus Health
Johnson and Johnson
Deloitte
Queensland Health
McKesson
Chinese Patent Office

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 064211

« Back to Dashboard

NDA 064211 describes TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE, which is a drug marketed by Akorn Inc, Bausch And Lomb, and Sandoz Inc, and is included in three NDAs. It is available from fifteen suppliers. Additional details are available on the TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE profile page.

The generic ingredient in TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE is polymyxin b sulfate; trimethoprim sulfate. There are twelve drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate; trimethoprim sulfate profile page.
Summary for 064211
Tradename:TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
Applicant:Sandoz Inc
Ingredient:polymyxin b sulfate; trimethoprim sulfate
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 064211
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE polymyxin b sulfate; trimethoprim sulfate SOLUTION/DROPS;OPHTHALMIC 064211 ANDA Rebel Distributors Corp 21695-335 E 21695-335-10
TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE polymyxin b sulfate; trimethoprim sulfate SOLUTION/DROPS;OPHTHALMIC 064211 ANDA A-S Medication Solutions 50090-2925 N 50090-2925-0

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength10,000 UNITS/ML;EQ 1MG BASE/ML
Approval Date:Apr 13, 1998TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Deloitte
Julphar
Fish and Richardson
Chubb
Harvard Business School
Cerilliant
Teva
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.